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▼The development of artificial chromosome vectors in a
variety of host organisms has allowed clonal libraries to
be produced that contain many equivalents of a target
genome. One such vector, pYAC4 (Ref. 1) propagated in
the host Saccharomyces cerevisiae, is used extensively in long-
range physical mapping projects. Genomic libraries of large
inserts and with deep coverage are being developed for a
range of organisms.
Inverse PCR (IPCR) involves the restriction and later self
ligation of DNAs to formdiscrete circular particles. Oligonu-
cleotide primers facing ‘outwards’ from known sequences
are used to amplify by PCR target particles containing in-
serts of interest. Using primer sets designed to flank both
vector cloning sites and specific endonclease sites found
within the vector arms, fragments of cloned insert can
be recovered in a form openly accessible to sequencing
(Ref. 2).
IPCR forms the basis of several well-established protocols
for the rapid recovery of pYAC4 insert ends, an integral re-
quirement of strategies for chromosomewalking and contig
building.
A YAC vector, pRML, has been developed that is capa-
ble of containing larger inserts than pYAC4 (Ref. 3). A
mouse genomic DNA library using the pRML vector has
been constructed (Ref. 4) and is the primary resource in
a project aiming to produce a physical map of the entire
mouse genome (http://www.genome.wi.mit.edu:80/cgi-
bin/mouse/index). During the development of the pRML
vector, sequences used in previous pYAC4 end clone recov-
ery IPCR strategies were removed.
Here we describe a modified IPCR protocol capable of
selective amplification of pRML insert ends using novel
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oligonucleotide primer−restriction endonuclease combina-
tions specific for the left (CEN4) and right (ARSH4) vector
arms.
Protocol
1. DNA agarose blocks were prepared from individual
clones using standard procedures (Ref. 5).
2. Half an agarose block per reaction was digested to com-
pletion in 3 h in 200 µl reactions containing 10 U of
either BclI (New England Biolabs), Cac8I (New Eng-
land Biolabs) (left, end capture), MseI (New England
Biolabs), DdeI (New England Biolabs) (right, end cap-
ture) or Sau3AI (New England Biolabs) (left and right
end capture) restriction endonucleases. These restric-
tion enzymes were chosen on the basis of the posi-
tion of their recognition sequences relative to the EcoRI
cloning site (within 200 bp) and their frequency of di-
gestion (4−6 bp recognition site). Enzymes cut at po-
sitions −135 (BclI), −156 (Cac8I), +113 (MseI), +104
(DdeI), −135 (Sau3AI) and +62 (Sau3AI) from the pRML
EcoRI cloning site.
3. Following digestion, each reaction was heated at 65◦C
for 10 min. DNA was extracted twice with phe-
nol, once with phenol−chloroform−isoamylalcohol
and once with chloroform−isoamylalcohol and subse-
quently precipitated with 0.3 M NaOAC and two vol-
umes of 100% ethanol (Ref. 6). Sample pellets were re-
suspended in50 µl sterile distilled water, an aliquot of
which was run on an agarose gel to estimate concentra-
tion. Stock dilutions were adjusted to a concentration
of 10−50 ng/µl.
4. Ten-microlitre self-ligation reactions were set up for
each of the five digestions containing 10 U T4 DNA lig-
ase (New England Biolabs) and 10−50 ng digested YAC
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Table 1. Oligonucleotide primer sequences used in
pRML end capture procedure
Primer Primer
name positiona 5′ to 3′ Sequence
LF −30 to −9 CGCTACGTAAATTAACCCTCA
LR −35 to −55 AGCTGTCAAACATGAGCTGG
RF +35 to +54 GTATTACGCGCGTCGACGG
RR +32 to +12 TCACTATAGGGCGAATTGGG
aAll primer positions are given in base pairs relative to the EcoRI
cloning site at position 0.
Table 2. Oligonucleotide primer sequences designed
to amplify novel STS markers from captured
sequences of YAC 359 E9
Derived from
Primer YAC 359
name E9 end 5′ to 3′ Sequence
STS1F Left CCACTGTAGGAACTCAGGG
STS1R Left AAGCAGTAGGAACAGGGTGG
STS2F Right ATATTGGCCACTGTGTGTATGC
STS2R Right TGGCTTAGCCAGTAAGTCAGC
(Research Genetics) DNA template . Reactions were left
for 14 h at 14◦C as recommended by the manufacturer.
5. Five-microlitre aliquots of the ligation reaction were
directly amplified in a 100 µl reaction using 4 U Taq
polymerase (Life Technologies) in the presence of 10
µl of 10 × Taq polymerase buffer and 1.5 mM Mg2+
solution, 0.2 mM dNTPs (Pharmacia) and 200 ng of
each of the relevant primers : LF and LR for left end
recovery, RF and RR for right end recovery (Table 1).
PCRs were performed using anOmnigene thermocycler
(Hybaid) under the following conditions: (95◦C, 4min)
× 1, [(94◦C, 30 s) × 1, (60◦C, 30 s) × 1, (72◦C, 1min 30
s) × 1] × 30, (72◦C, 4 min) × 1.
6. Five microlitres of each PCR product was run on a 1%
agarose gel to check for amplification. Products were
concentrated using Microcon-100 columns (Amicon),
sequenced using a Prism dye terminator kit (Perkin-
Elmer) and analysed on a 373A automated DNA se-
quencer (Perkin-Elmer).
Six pRML YACs (356 E9, 177 F12, 183 F2, 421 D6, 183 G2
and 133 D6) were obtained from the doubly linked contig
WC-608. Both left and right inserts were successfully re-
covered from all six clones. Novel STSs were identified in
captured sequence of both ends of a single YAC (359 E9).
Primers designed to these sequences (Table 2) were shown
to amplify the initial clone and total mouse genomic DNA
FIGURE 1. PCR amplification using STS1 and STS2, showing that the
captured sequences map back to the target pRML clone 359 E9. Lane 1,
Gibco kb ladder; lane 2, 359 E9 STS1 against B6C3HF1 total mouse;
lane 3, 359 E9 STS1 against 359 E9 YAC DNA; lane 4, 359 E9 STS1
against pRML YAC 177 F12; lane 5, 359 E9 STS1 H2O control; lane 6,
blank; lane 7, Gibco kb ladder; lane 8, 359 E9 STS2 against B6C3HF1
total mouse; lane 9, 359 E9 STS2 against 359 E9 YAC DNA; lane 10, 359
E9 STS2 against pRML YAC 177 F12; lane 11, 359 E9 STS2 H2O control.
but failed to amplify pRML clone 177 F12, verifying the ori-
gin of the captured end fragment to be that of the specified
insert ends and not derived from vector or host (Fig. 1).
STS PCRs were performed in a 25 µl reaction (1 U Taq
polymerase, 1 × Taq polymerase buffer, 10% DMSO, 200
mM dNTPs, 10 pmol primer) under the following condi-
tions: (95◦C 30 s) × 1, [(94◦C 45 s) × 1, (annealing temp 1
min) × 1, (72◦C 30 s) × 1] × 33, (72◦C 2 min) × 1. YAC 359
E9 left end (STS1) primers (STS1F and STS1R) amplify at an
annealing temperature of 62◦C in the presence of 1.0 mM
Mg2+. Right end (STS2) primers (STS2F and STS2R) amplify
at an annealing temperature of 53◦C using 1.5 mM Mg2+.
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Products Used
Sau3A I: Sau3A I from New England BioLabs
T4 DNA ligase: T4 DNA ligase from Boehringer
Mannheim
ligase: ligase from Boehringer Mannheim
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Taq DNA polymerase: Taq DNA polymerase from
PE Applied Biosystems
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Promega Corporation
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Pharmacia
Taq polymerase: Taq polymerase from Bioline
Taq polymerase: Taq polymerase from Advanced
Biotechnologies
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Bioline
dNTP: dNTP from Promega Corporation
dNTP: dNTP from PE Applied Biosystems
dNTP: dNTP from Pharmacia
dNTP: dNTP from Promega Corporation
dNTP: dNTP from Boehringer Mannheim
Microcon-100 columns: Microcon-100 columns
from Amicon Inc
Prism dye terminator kit: Prism dye terminator
kit from PE Applied Biosystems
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